Artificial intelligence (AI) is edging closer to the bioreactor. But its progress is being slowed by an unglamorous obstacle: the disarray of bioprocessing data. According to Phil Mounteney, vice ...

Also Read: ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug Specific key efficacy findings from cohort B (N=80) of the Phase 2/3 open-label, single-arm ...

A newly enacted New York law requires retailers to say whether your data influences the price of basic goods like a dozen eggs or toilet paper, but not how. If you’re near Rochester, New York, the ...

IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced ...

On Election Day, Peter Hubbard was one of two Democratic candidates who took a decisive—and surprising—victory in Georgia. Hubbard was elected to the Georgia Public Service Commission, the body that ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in Sjögren’s disease, the pharma reported at the American College of ...

Paul Thomas Anderson utilized VistaVision to make his latest movie, “One Battle After Another,” which stars Leonardo DiCaprio as a bumbling, washed-up revolutionary trying to save his daughter Gregory ...

Your inbox could contain real money—or a trap. I made two fake settlement claim sites in five minutes, and I'm here to tell you how to tell a legit settlement notice site from a data-stealing fake. I ...